| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |